FindTrial
Sign In

Study on the efficacy and safety of remidazolam and propofol in pediatric patients undergoing tonsillectomy

Study on the sedative effect and safety of remidazolam and propofol in pediatric patients undergoing tonsillectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073770
Enrollment
Unknown
Registered
2023-07-20
Start date
2023-07-21
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tonsillectomy

Interventions

Normal weight remidazolam group:None
obesity remidazolam group:None
Normal weight propofol group:None
obesity remidazolam propofol group :None

Sponsors

the Third People’s Hospital of Changzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 12 Years

Inclusion criteria

Inclusion criteria: This study evaluated and analyzed 160 children aged 5-12 who underwent tonsillectomy at the Third People's Hospital of Changzhou from July 2023 to August 2023, with a physical condition of American Society of Anesthesiologists (ASA) I-II.

Exclusion criteria

Exclusion criteria: Children taking medications that could affect cardiovascular function or related adverse reactions were excluded.

Design outcomes

Primary

MeasureTime frame
SBP;DBP;HR;SpO2;—

Countries

Chnia

Contacts

Public ContactWeibin Xie

the Third People’s Hospital of Changzhou

gaoshiguang200619@126.com+86 138 6128 5535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026